04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
From independent contractors to privacy to arbitration agreements - the California Legislature was b...
Read More >
Employers are scrambling to stay on top of ever-evolving cannabis laws across the country, but feder...
Read More >
The National Labor Relations Board ("NLRB") is expected to rewrite its rules protecting employees wh...
Read More >
With the resumption of the current legislative session on August 12, 2019, the California Senate App...
Read More >
In Garcia v. Communities in Schools of Brazoria County, a director sued a nonprofit’s board for bre...
Read More >
State governments are issuing orders suspending the full or partial operations of “non-essential” ...
Read More >